Orchard Therapeutics plc ORTX
16.70 +16.70
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 22.66M | 1.68M | 2.60M | 2.51M | 2.08M | |
| 15.88M | 1.45M | 1.74M | 1.71M | 1.65M | |
| -127.09M | -140.43M | -156.98M | -172.87M | -235.03M | |
| -150.66M | -144.58M | -151.98M | -163.42M | -230.50M | |
| -11.80 | -11.70 | -15.30 | -17.50 | -102.20 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 68.42M | 55.91M | 55.13M | 19.05M | 335.84M | |
| 218.91M | 322.41M | 280.94M | 399.28M | 366.04M | |
| 120.64M | 112.46M | 102.50M | 100.09M | 54.70M | |
| 58.09M | 59.48M | 58.17M | 45.91M | 0 | |
| 98.26M | 209.95M | 178.43M | 299.19M | 311.34M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -75.99M | -125.10M | -126.27M | -166.13M | -97.54M | |
| 90.56M | -32.16M | 157.38M | -309.36M | -4.03M | |
| -693.00K | 158.07M | 3.94M | 157.45M | 354.86M | |
| 1.45M | -2.13M | -10.79M | -4.37M | -4.03M | |
| 12.46M | 777.00K | 36.08M | -316.36M | 249.82M |